Renaissance Technologies (RenTech)'s DERM Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 229,700 shares of Journey Medical Corporation (DERM) worth $1.63 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in DERM, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 240,100 shares. Largest reduction occurred in Q4 2024, reducing 32,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Journey Medical Corporation (DERM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Journey Medical Corporation (DERM) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -12,800 | Reduce 5.28% | 229,700 | $7.08 |
| Q1 2026 | -1,500 | Reduce 0.61% | 242,500 | $4.69 |
| Q4 2025 | -3,900 | Reduce 1.57% | 244,000 | $7.71 |
| Q3 2025 | +4,400 | Add 1.81% | 247,900 | $7.12 |
| Q2 2025 | +5,500 | Add 2.31% | 243,500 | $7.18 |
| Q1 2025 | +2,000 | Add 0.85% | 238,000 | $5.90 |
| Q4 2024 | -32,200 | Reduce 12.01% | 236,000 | $3.91 |
| Q3 2024 | +4,175 | Add 1.58% | 268,200 | $5.65 |
| Q2 2024 | -6,575 | Reduce 2.43% | 264,025 | $5.64 |
| Q1 2024 | +9,600 | Add 3.68% | 270,600 | $3.68 |
| Q4 2023 | +240,100 | Add 1148.80% | 261,000 | $5.76 |
| Q3 2023 | +9,400 | Add 81.74% | 20,900 | $2.73 |
| Q2 2023 | +11,500 | New Buy | 11,500 | $0.00 |
| Q2 2022 | -15,600 | Sold Out | 0 | $0.00 |
| Q1 2022 | +15,600 | New Buy | 15,600 | $4.81 |
Renaissance Technologies (RenTech)'s Journey Medical Corporation Investment FAQs
Renaissance Technologies (RenTech) first purchased Journey Medical Corporation (DERM) in Q1 2022, acquiring 15,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Journey Medical Corporation (DERM) for 15 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Journey Medical Corporation (DERM) was in Q4 2023, adding 261,000 shares worth $1.5 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 229,700 shares of Journey Medical Corporation (DERM), valued at approximately $1.63 M.
As of the Q2 2026 filing, Journey Medical Corporation (DERM) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Journey Medical Corporation (DERM) was 270,600 shares, as reported at the end of Q1 2024.